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a b s t r a c t
INTRODUCTION: Mucormycosis caused by order mucorales, an ubiquitous saprophytic mold found in
soil and organic matter worldwide, is a rare but invasive opportunistic fungal infection. Gastrointestinal
mucormycosis is the most uncommon clinical presentation being particularly rare, accounted for 4–7%
of all cases.
PRESENTATIONOF CASE:We report an unusual presentation ofmucormycosis of ascending colon thatwas
simulating carcinoma colon.
DISCUSSION: GI mucormycosis most commonly involves the stomach (57.5%), followed by the colon
(32.3%) and the ileum (6.9%). Initial presentations may be abdominal pain and distension, fever, and
diarrhoea. Colonic mucormycosis presenting as a mass with altered bowel habit, melena and abdominal
pain in our case is extremely difﬁcult to differentiate it from carcinoma colon. A deﬁnitive diagnosis of
mucormycosis is almost always ascertained by histopathological evidence of fungal invasion of tissue.
CONCLUSION: Knowing these unusual presentations of this disease, surgeon need to maintain a high
index of suspicion and perform timely and appropriate diagnostic evaluation to improve patient out-
come. Promptdiagnosis, reversal of predisposing conditions, and aggressive surgical debridement remain
cornerstones of therapy for this deadly disease.
© 2015 The Authors. Published by Elsevier Ltd. on behalf of Surgical Associates Ltd. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Mucormycosis caused by order mucorales [1,2], an ubiquitous
saprophytic mold found in soil and organic matter worldwide, is
a rare but invasive opportunistic fungal infection. The disease in
humans is mainly limited to people with risk factors such as neu-
tropenia [3–6], immune deﬁciencies [2–4,7,8], malignant disease
[2–8], malnutrition [3,4], diabetes [2–8], trauma [2,6], organ trans-
plantation [2–5,7], and iron overload [3–6]. The clinical infection
due to mucorales includes rhinocerebral, pulmonary, cutaneous,
gastrointestinal and disseminated diseases [3,5].
Gastrointestinal mucormycosis is the most uncommon clinical
presentation being particularly rare, accounted for 4–7% of all cases
[9].We report an unusual presentation ofmucormycosis of ascend-
ing colon that was simulating carcinoma colon.
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2. Presentation of case
This study presents the case of a 42 year-oldHindumale, known
diabetic with an one-year history of waxing and waning right-
sided abdominal pain associated with a change in bowel habits &
melena admitted to our hospital with chief complaints of abdom-
inal pain and no passage of stool since two days which was not
associated with vomiting or fever. On examination, there was a
tender irregular lump of size about 8×10 cm felt on right lumbar
region extending upto right hypochondrium. Per rectal examina-
tion is normal except ﬁnger stall being smeared with blood. Other
systemexamination revealed no abnormalities. Laboratory investi-
gations were normal except FBS 186mg/dl, 1 h PPBS 248mg/dl and
HbA1c 8.5. Ultrasonography of abdomen & pelvis showed thick-
ened, irregularwall of the ascending colon near the hepatic ﬂexure.
Upper GI endoscopy revealed normal. On contrast enhanced CT
(CECT) of whole abdomen (triple phase), there was an irregular
bowelwall thickening (15–19mm)with a nodular polypoidalmass
lesion seen involving ascending colon & extending upto hepatic
ﬂexure showing moderate to avid enhancement on arterial phase
(Fig. 1), persistent contrast enhancement on portal phase & con-
trast wash out on delayed phase with multiple enlarged pericolic
lymph nodes (Fig. 2). Colonoscopy was performed which revealed
a polypoid nodular growth in ascending colon proximity to hepatic
http://dx.doi.org/10.1016/j.ijscr.2015.02.021
2210-2612/© 2015 The Authors. Published by Elsevier Ltd. on behalf of Surgical Associates Ltd. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).
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Fig. 1. CECT of whole abdomen showing an irregular bowel wall thickening
(15–19mm) with a nodular polypoidal mass lesion.
ﬂexure with narrowed lumen and the scope was not negotiable
further (Fig. 3). Multiple biopsies were taken which gave non-
speciﬁc inﬂammatory lesion. So, inﬂammatory mass of colon was
suspected, but clinically, carcinoma of ascending colon could not
be excluded and was planned for surgery.
Right hemicolectomy with an end to end ileocolic anastomo-
sis was done and a mass lesion in the ascending colon, near to
hepatic ﬂexure not associated with any enlarged lymph nodes
seen. Histopathology of the specimen showed patchy destruction
of colonic mucosa with dense inﬁltration of acute inﬂammatory
cells in the ulcerated area, multiple foci of abscess comprising
of polymorphs and nuclear debris in different layers of the wall
starting from mucosa to serosa, presence of epithelial histiocytes
and multinucleated giant cells, clumps as well as discrete fun-
gal hyphae within these inﬂammatory areas, infrequently septate,
uneven wide hyphae having wide angle branching in these clus-
ters oncolonicmass sections (Fig. 4). Serosal nodule section showed
Fig. 2. CECT of whole abdomen showing an irregular bowel wall thickening with
a nodular polypoidal mass lesion seen involving ascending colon & extending upto
hepatic ﬂexure with multiple enlarged pericolic lymph nodes.
Fig. 3. Colonoscopic view of ascending colon proximity to hepatic ﬂexure with a
polypoid nodular growth with narrowed lumen.
necroinﬂammatory changes asdescribedabovewith clumpsof fun-
gal hyphae andarea of angioinvasion& thrombus formation (Fig. 5).
Upon receiving the pathology report, systemic intravenous
amphotericin B treatment was initiated as colonic mucormycosis
was conﬁrmed on histopathology. Patient recovered well and was
discharged on 14th postoperative day.
Fig. 4. Histopathology showing presence of epithelial histiocytes, multinucleated
giant cells, clumps as well as discrete fungal hyphae within an inﬂammatory area
having wide angle branching.
Fig. 5. Serosal nodule section showing area of angioinvasion& thrombus formation.
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3. Discussion
Mucormycosis is a rare, opportunistic infection caused by the
fungi from the class Zygomycetes, order mucorales. The fungus
exists in two forms, the infective sporangiospores and the hyphal
form, responsible for tissue necrosis and dissemination. Depend-
ing on the site of involvement, mucormycosis can be classiﬁed as
rhinocerebral, pulmonary, cutaneous, GI, central nervous systemor
disseminated mucormycosis [3].
GI mucormycosis is the rarest of all forms of mucormycosis,
accounting for approximately 7% of all cases [10]. GI mucormy-
cosis most commonly involves the stomach (57.5%), followed by
the colon (32.3%) and the ileum (6.9%). This rare and oppor-
tunistic infection has been reported in neonates, probably due to
their immature immunity, presenting as necrotizing enterocolitis.
Fewer than 20 cases of GI mucormycosis with colonic involve-
ment have been reported in the past two decades [11]. GI infection
most probably results from ingestion of fungal spores. Being an
opportunistic infection, some degree of immunocompromised sta-
tus is almost always associated with GI mucormycosis. The most
common underlying risk factors for mucormycosis include poorly
controlled diabetes mellitus, administration of high-dose systemic
corticosteroids in solid organ and hematopoietic stem cell trans-
plantation, penetrating trauma or burns, persistent neutropenia
and deferoxamine-based therapy [12]. In our case, patient is a
known case of type-II diabetes mellitus for last 10 years and he was
not taking any antidiabetic medications since 2 years, resulting in
uncontrolled diabetes.
A typical gastrointestinal lesion consists of a dark ulcer with
sharply demarcated edges and with necrosis and thrombosis in
adjacent vessels. The infection canextend fromthe lumenof the gut
and may cause obstruction, perforation or bleeding. Initial presen-
tationsmaybeabdominal pain anddistension, fever, anddiarrhoea.
If there is extensive bowel involvementwithmultiple ulcers caused
by the fungal infection, it may present with gastrointestinal bleed-
ing or even visceral perforation at late presentation [10]. Even
though melena is a feature of upper GI bleeding, because we failed
to demonstrate any speciﬁc lesion causing an upper GI bleed, it was
presumed that colonic mucormycosis was responsible for melena
in this patient.
Lack of pathognomic clinical features renders early diagnosis
of GI mucormycosis very difﬁcult. Although a vigilant clinician
can suspect the possibility of GI mucormycosis in a patient with
traditional risk factors, the same cannot be expected in a patient
without traditional risk factors. The diagnosis of mucormycosis is
rarely suspected and antemortemdiagnosis ismade in only 25–50%
of cases [13]. Colonic mucormycosis presenting as a mass with
altered bowel habit, melena and abdominal pain is extremely difﬁ-
cult to differentiate it from carcinoma colon. A deﬁnitive diagnosis
ofmucormycosis is almost always ascertained by histopathological
evidence of fungal invasion of tissue. On CECT of whole abdomen,
an irregular bowel wall thickening with a nodular polypoidal mass
lesion, involving ascending colon & extending upto hepatic ﬂexure
withmultiple enlarged pericolic lymphnodes seenwhich gave high
suspicion of malignancy. In colonoscopy also we found same nodu-
lar polypoidal growth obstructing the lumen of ascending colon
near hepatic ﬂexure but colonoscopic biopsy showed nonspeciﬁc
inﬂammatory lesion. Diagnosis depends on histological examina-
tion for the presence of predominantly aseptate wide hyphae with
focal bulbous and non dichotomous branching occasionally at right
angles [14]. Over 94% of sampled tissues also show infraction and
angioinvasion on histology examination [15] as in our case.
Four factors are critical for eradicating mucormycosis: rapid-
ity of diagnosis, reversal of the underlying predisposing factors
(if possible), appropriate surgical debridement of infected tissue,
and appropriate antifungal therapy. Early diagnosis is important
because small, focal lesions can often be surgically excised before
they progress to involve critical structures or disseminate [16].
Unfortunately, there are no serologic or PCR-based tests to allow
rapid diagnosis. As mentioned, autopsy series have reported that
up to half the cases of mucormycosis are diagnosed postmortem
[17–19], underscoring the critical need to maintain a high index
of clinical suspicion and to aggressively pursue diagnostic biopsy.
Correcting or controlling predisposing problems is also essential
for improving the treatment outcome. In diabetic ketoacidotic
patients, hyperglycemia and acidemia should be corrected.
There are no recommendations regarding treatment speciﬁc
to gastrointestinal infection. We managed our patient with right
hemicolectomy and intravenous high dose (1mg/kg per day)
amphotericin B started after histopathological conﬁrmation of
colonic mucormycosis.
4. Conclusion
Mucormycosis is an increasingly common infection in immuno-
compromised patients. Knowing these unusual presentations of
this disease, surgeonneed tomaintain a high index of suspicion and
perform timely and appropriate diagnostic evaluation to improve
patient outcome. Prompt diagnosis, reversal of predisposing con-
ditions, and aggressive surgical debridement remain cornerstones
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